United States· US:64950-175_dd8b277c-6ec2-4e0b-9aec-c64089e18cfe
RenThyroid
A medicinal product containing levothyroxine; liothyronine, registered in United States by Genus Lifesciences.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LEVOTHYROXINE; LIOTHYRONINE
- Manufacturer
- Genus Lifesciences
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc116495017501100 TABLET in 1 BOTTLE (64950-175-01)
- ndc11649501750990 TABLET in 1 BOTTLE (64950-175-09)
- ndc1164950-175-01
- ndc1164950-175-09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/00cd238c-c2eb-47df-aa07-0bdd76659a3b GET /v1/drugs/00cd238c-c2eb-47df-aa07-0bdd76659a3b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "114; 27",
"substance": "LEVOTHYROXINE; LIOTHYRONINE",
"productndc": "64950-175",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "ug/1; ug/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about levothyroxine; liothyronine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.